PM Gopinath¹* and Sahityalakshmi Manoharan²

¹ Director of Reproductive Medicine, Kauvery Hospital , Vadapalani, Chennai, Tamilnadu, India
¹Associate Consultant, Reproductive Medicine, Kauvery Hospital, Vadapalani, Chennai, Tamilnadu, India

*Corresponding Author: PM Gopinath, Director of Reproductive Medicine, Kauvery Hospital, Vadapalani, Chennai, Tamilnadu, India.

Received: December 27, 2024; Published: December 31, 2024

Abstract

The search for optimal therapy for endometriosis continues, and the use of dietary supplements is gaining attention. Supplements can be employed for their anti-inflammatory, antioxidant, anti-proliferative, and immune-modulatory properties. A retrospective randomized observational study was conducted on 5017 cases, where 2814 individuals were administered a combination of Resve ratrol, N-acetylcysteine (NAC), Curcumin, and Vitamin D, along with other modes of treatment, while 2203 were treated without the combination. Data on recurrence and pain resistance (determined based on feedback during each clinical visit) have been presented, treatment for endometriosis. analyzed, and discussed. Based on these observations, the findings suggest that dietary supplements can be used as a complementary

Keywords: Dietary Supplements; Complementary Therapies; Endometriosis

References

1. Zondervan KT., et al. “Endometriosis”. Nature Reviews Disease Primers 4.1 (2018): 9. 2. Laganà, Antonio Simone., et al. “Stem cell trafficking during endometriosis: may epigenetics play a pivotal role?” Reproduction Science 25.7 (2018): 978-979. 3. Laganà Antonio Simone., et al. “Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis”. Medical Hypotheses 103 (2017): 10-20. 4. Lagana Antonio Simone., et al. “Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease”. Gynecology and Endocrinology 36.5 (2020): 441-444. 5. Laganà Antonio Simone., et al. “The pathogenesis of endometriosis: molecular and cell biology insights”. International Journal of Molecular Sciences 20.22 (2019): 5615. 6. Johnson NP., et al. “Consensus on current management of endometriosis”. Human Reproduction 28.6 (2013): 1552-1568. 7. Holt VL and Weiss NS. “Recommendations for the design of epidemiologic studies of endometriosis”. Epidemiology 11.6 (2000): 654-659. 8. Burney RO., et al. “Pathogenesis and pathophysiology of endometriosis”. Fertility and Sterility 98 (2012): 511-519. 9. Shafrir AL., et al. “Pelvic floor, abdominal and uterinetenderness in relation to pressure pain sensitivity among women with endometriosis and chronic pelvic pain”. European Journal of Obstetrics and Gynecology and Reproductive Biology 264 (2021): 247-253. 10. Vannuccini S., et al. “Hormonal treatments for endometriosis: The endocrine background”. Reviews in Endocrine and Metabolic Disorders 23 (2021): 333-355. 11. Zondervan KT., et al. “Endometriosis”. The New England Journal of Medicine 382.13 (2020): 1244-1256. 12. Garcia-Fernandez J and García-Velasco JA. “Endometriosis and reproduction: what we have learned”. Yale Journal of Biology and Medicine 93.4 (2020): 571-577. 13. Prosperi Porta R., et al. “Effects of breastfeeding on endometriosis-related pain: a prospective observational study”. International Journal of Environmental Research and Public Health 18.20 (2021): 10602. 14. Missmer SA., et al. “Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors”. American Journal of Epidemiology 160.8 (2004): 784-796. 15. Hirsch M., et al. “The prevalence of endometriosis in adolescents with pelvic pain: a systematic review”. Journal of Pediatric and Adolescent Gynecology 33 (2020): 623-630. 16. Vannuccini S., et al. “Hormonal treatments for endometriosis: The endocrine background”. Reviews in Endocrine and Metabolic Disorders 23 (2021): 333-355. 17. Zondervan KT., et al. “Endometriosis”. The New England Journal of Medicine 382.13 (2020): 1244-1256. 18. Garcia-Fernandez J and García-Velasco JA. “Endometriosis and reproduction: what we have learned”. The Yale Journal of Biology and Medicine 93.4 (2020): 571-577. 19. Somigliana E., et al. “Vitamin D reserve is higher in women with endometriosis”. Human Reproduction 22.8 (2007): 2273-2278. 20. Miyashita M., et al. “Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis”. The Journal of Clinical Endocrinology and Metabolism 101.6 (2016): 2371-2379. 21. Agic A., et al. “Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers”. Reproductive Sciences 14.5 (2007): 486-497.

Citation

Citation: PM Gopinath and Sahityalakshmi Manoharan. “Retrospective Observational Study of a Combination of Resveratrol, N-acetylcysteine (NAC), Curcumin, and Vitamin D for the Treatment of Endometriosis and Its Recurrence". Acta Scientific Dental Sciences 7.1 (2025): 13-19.

Copyright

Copyright: © 2025 PM Gopinath and Sahityalakshmi Manoharan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.